Denali Therapeutics Inc. (DNLI)
Analyst consensus, price target and coverage. 16 analysts, updated daily.
Analyst votes
How the ratings break down
20 ratings on record
- Strong Buy2
- Buy17
- Hold1
- Underperform0
- Sell0
Price targets
Where the estimates sit
How far apart analysts are on this name.
Low 27.00
Mean 35.44
High 42.00
share price 25.27 mean target 35.44. Analysts are spread 56% apart, and the share price sits below every target on record.
Most recent action
Last rating change
| Firm | UBS |
|---|---|
| Date | 2026-08-07 |
| Change | Buy → Buy |
Size and liquidity
Key statistics
| Market cap | 4.04B USD |
|---|---|
| Cap class | Mid |
| Average volume | 1,842,108 |
| Dollar volume per day | 46.6M |
| Liquidity | High |
| Internal score | 87.2 / 100 |
Recommendation
How it moved, scan by scan
2 scans on record
| Scan | Move | Consensus | Score | SB | Buy | Hold | Und | Sell |
|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | = | Strong Buy | 1.95 | 2 | 17 | 1 | 0 | 0 |
| 2026-08-11 | · | Strong Buy | 1.95 | 2 | 17 | 1 | 0 | 0 |
Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. ▲ more positive, ▼ more negative, = unchanged.
History
Price target over time
2 daily points recorded
| Date | Price | Target | Upside | Consensus |
|---|---|---|---|---|
| 2026-08-13 | 25.27 | 35.44 | +40.2% | Strong Buy |
| 2026-08-11 | 24.99 | 34.50 | +38.1% | Strong Buy |
Similar coverage
Comparable mid-cap names
Closest upside among companies of the same size.